EUROPEAN COMMISSION DIRECTORATE-GENERAL III INDUSTRY Industrial affairs III: Consumer goods industries Pharmaceuticals and Cosmetics

Similar documents
GUIDELINE ON THE CATEGORISATION OF EXTENSION APPLICATIONS (EA) versus VARIATIONS APPLICATIONS (V) OCTOBER 2003

EUROPEAN COMMISSION HEALTH AND FOOD SAFETY DIRECTORATE-GENERAL VOLUME 2C. Guidelines. Medicinal products for human use

GUIDANCE ON SUBMISSIONS FOR SAFETY EVALUATION OF SOURCES OF NUTRIENTS OR OF OTHER INGREDIENTS PROPOSED FOR USE IN THE MANUFACTURE OF FOODS

EUROPEAN COMMISSION HEALTH AND FOOD SAFETY DIRECTORATE-GENERAL VOLUME 2C. Guidelines. Medicinal products for human use

A GUIDELINE ON CHANGING THE CLASSIFICATION FOR THE SUPPLY OF A MEDICINAL PRODUCT FOR HUMAN USE

Single market, regulatory environment, industries under vertical legislation Pharmaceuticals : regulatory framework and market authorisations

Medicinal Products for Human Use HOMEOPATHIC MEDCINAL PRODUCT FOR HUMAN USE. December 2005

Quality of medicines in Portugal: a retrospective review of medicine recalls ( ) Ana Teresa Reis Bruna Berardo Rui Loureiro

EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL

COMMISSION IMPLEMENTING DECISION. of

Principals and dosage forms of pharmaceutics

Opinion on the safety assessment of phospholipds obtained from egg yolk as food produced using a new process

WHAT DO MANUFACTURERS AND IMPORTERS HAVE TO DO TO PREPARE FOR EU MEMBERSHIP?

(Adopted by the Committee of Ministers on 19 January 2011 at the 1103rd meeting of the Ministers Deputies)

Opinion. of the Scientific Committee on Food

Notification of a Body in the framework of a technical harmonization directive

Notification of a Body in the framework of a technical harmonization directive

<1151> Pharmaceutical Dosage Forms and <1152> Animal Drugs for Use in Animal Feeds

Notification of a Body in the framework of a technical harmonization directive

OVERVIEW OF COMMENTS RECEIVED ON COMMUNITY HERBAL MONOGRAPH ON HAMAMELIS VIRGINIANA L., FOLIUM (EMEA/HMPC/114586/2008)

OPINION ON A MALTITOL SYRUP NOT COVERED BY THE CURRENT SPECIFICATIONS

Notice Information: - Advisory 01 November 2010

Notification of a Body in the framework of a technical harmonization directive

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/17

European Medicines Agency decision

DIRECTIVES. (Text with EEA relevance)

European Medicines Agency decision

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

European Medicines Agency decision

European Medicines Agency decision

MINISTRY OF INDUSTRY AND TRADE OF THE RUSSIAN FEDERATION No. GMP-00903/18/TR STATEMENT of compliance of manufacturer (foreign manufacturer) of medicin

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

Topics covered by the talk

IPEC Europe Suggested Alternative (if none then original text is clear and needs no alteration) Purpose and Scope

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

COMMISSION OF THE EUROPEAN COMMUNITIES COMMISSION DECISION. of 29-VIII-2008

EUROPEAN MEDICINES AGENCY DECISION. of 11 August 2009

European Medicines Agency decision

European Medicines Agency decision

European Medicines Agency decision

European Medicines Agency decision

European Medicines Agency decision

General Concepts in the European Pharmacopoeia. Anne-Sophie Bouin European Pharmacopoeia Department, EDQM, Council of Europe

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents

COMMISSION OF THE EUROPEAN COMMUNITIES COMMISSION DECISION. of

COMMISSION OF THE EUROPEAN COMMUNITIES COMMISSION DECISION. of 18-XII-2007

Risk Classification of Excipients. Presentation to Stakeholders Meeting Brussels 14 th May 2009 Frithjof Holtz

European Medicines Agency decision

European Medicines Agency decision

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

European Medicines Agency decision

COMMISSION DELEGATED REGULATION (EU) /... of XXX

EUROPEAN MEDICINES AGENCY DECISION. of 24 June 2008

European Medicines Agency decision

European Medicines Agency decision

Guide to Registration of Homeopathic Veterinary Medicinal Products

European Medicines Agency decision

COMMISSION REGULATION (EU) / of XXX

Good Laboratory Practice. EU-Serbia screening meeting Brussels, 19 June 2014

MEDICINES CONTROL AGENCY GUIDELINE FOR REGISTRATION OF FOOD/NUTRITIONAL/DIETARY SUPPLEMENTS IN THE GAMBIA

OPINION ON AN ADDITIONAL LIST OF MONOMERS AND ADDITIVES FOR FOOD CONTACT MATERIALS

Cooperation between HALMED and GMP Inspectorate in supervision of manufacturers: Croatia s experience so far

European Medicines Agency decision

European Medicines Agency decision

European Medicines Agency decision

VOLUME 6A Procedures for marketing authorisation

TANZANIA FOOD AND DRUGS AUTHORITY

TANZANIA FOOD AND DRUGS AUTHORITY

This Administrative regulation will come into force on 1 st January 2018 and will remain so until further notice. Administrative Regulation No 3/2015

EUROPEAN MEDICINES AGENCY DECISION. of 22 September 2009

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

European Medicines Agency decision

European Medicines Agency decision

Draft Guideline on Pharmaceutical Development of Medicines for Paediatric Use. C. Nopitsch-Mai London 1

European Medicines Agency decision

PHARMACEUTICS I صيدالنيات 1 UNIT 1 INTRODUCTION

Wyss Zürich Regulatory Affairs Seminar

VICH GL58 Stability Testing of New Veterinary Drug Substances and Medicinal Products in Climatic Zones III and IV

EUROPEAN MEDICINES AGENCY DECISION. of 23 December 2008

EUROPEAN UNION. Brussels, 15 October 2007 (OR. en) 2005/0227 (COD) PE-CONS 3627/07 MI 149 ECO 83 SAN 123 CODEC 621

GUIDE TO REGISTER HOMEOPATHIC PRODUCTS FOR VETERINARY USE

Excipient Risk Assessment

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

COMMISSION IMPLEMENTING DECISION. of XXX

European Medicines Agency decision

EUROPEAN COMMISSION HEALTH AND FOOD SAFETY DIRECTORATE-GENERAL. PHARMACEUTICAL COMMITTEE 21 October 2015

Opinion of the Scientific Committee on Food on the 14th additional list of monomers and additives for food contact materials

MEDICINES ACT 395/1987. Unofficial translation; Amendments up to 1340/2010 included

European Medicines Agency decision

Changing practice to support service delivery

Annex I. Scientific conclusions and grounds for the variation to the terms of the Marketing Authorisation(s)

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

European Medicines Agency decision

This Administrative regulation will come into force on 1 st August 2013 and will remain so until further notice.

Guideline on pharmaceutical development of medicines for paediatric use

European Medicines Agency decision

REGULATION (EC) No.141/2000

STANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH SECTION ON GENERAL FOOD LAW. Summary Record of Meeting of 30 April 2012

Transcription:

EUROPEAN COMMISSION DIRECTORATE-GENERAL III INDUSTRY Industrial affairs III: Consumer goods industries Pharmaceuticals and Cosmetics Community Basic Format for Manufacturing Authorisation Explanatory Notes 1. Purpose The attached provides the basic format and content for manufacturing authorisation granted by the Competent Authorities of Community Member States in accordance with Article 16 of Council Directive 75/319/EC and Article 24 of Council Directive 81/851/EC. 2. Use by Competent Authorities in the EU This document describes the order in which information will appear in manufacturing authorisations and the basic content of each section. Otherwise manufacturing authorisations will reflect the individual requirements of the Competent Authorities and National Legislation. 3. Content of the Manufacturing Authorisation Manufacturing authorisations should contain, as a minimum, the information included in pages 1-3 in the attached model document, with the exception of sections 1 and 3 of Annex I which are optional (indicated as such in the text). The remaining pages consist of Annexes (2 to 7) which are optional and are to be used at the discretion of the Competent Authorities concerned. 4. Implementation It has been agreed (at the Control of Medicinal Products and Inspections Working Party on 18/12/98) that this model format will be introduced for all new and renewed manufacturing authorisations issued by the Competent Authorities of the EU Member States from July 1 st 1999 onwards. G:\E3\Common\Basic Format\basicformat-ENr.doc Rue de la Loi 200, B-1049 Bruxelles/Wetstraat 200, B-1049 Brussel - Belgium - Office: AN 88 1/37. Telephone: direct line 295.82.7480, exchange (+32-2)299.11.11. Fax: 296.15.20. Telex: COMEU B 21877. Telegraphic address: COMEUR Brussels.

MANUFACTURING AUTHORISATION - COMMUNITY BASIC FORMAT 1. Authorisation Number 2. Name of Manufacturer 3. Address of manufacturing site 4. Legally registered address of authorisation holder 5. Scope of Authorisation (Manufacturing operations* / Production Activities) See Annex 1 6. Dosage forms produced* See Annex 1 7. Legal Basis of Authorisation (Reference to Directives and National legislation implementing them) 8. Name of Responsible officer of the competent authority of the member state granting the manufacturing authorisation 9. Signature 10. Date Day / month / year Annexes attached Annex I Annexes 2*, 3*,4*,5*,6*, 7* (as required) * Optional 1

ANNEX I SCOPE OF AUTHORISATION: (Please delete the areas which do not apply) Human Medicinal Product Veterinary Medicinal Product 1 MANUFACTURING OPERATIONS (Categorised as per GMP Guideline) * 1.1 Purchase of Materials 1.2 Purchase of Products 1.3 Production 1.4 Release Quality Control 1.5 Storage 1.6 Distribution 1.7 Related Controls for these operations 2 PRODUCTION ACTIVITIES 2.1 Sterile products 2.1.1 Liquid dosage forms (Large Volume Parenterals) - aseptically prepared - terminally sterilised 2.1.2 Liquid dosage forms (Small Volume Parenterals) - aseptically prepared - terminally sterilised - eye drops 2.1.3 Semi-solid dosage forms 2.1.4 Solid dosage forms - solid fill - freeze-dried 2.2 Non-sterile products 2.2.1 Liquid dosage forms 2.2.2 Semi-solid dosage forms 2.2.3 Solid dosage forms - unit dose form (tablets, capsules, suppositories, pessaries) - multi dose form (powders, granules) 2.2.4 Medical gases 2.3 Biological products 2.3.1 Vaccines 2.3.2 Sera 2.3.3 Blood products 2.3.4 Other (describe: e.g. hormones, enzymes of human or animal origin, genetically engineered products) 2.4 Packaging only 2.4.1 Liquid dosage form 2.4.2 Semi-solid dosage form 2.4.3 Solid dosage form 2.4.4 Medical gases * Optional section 2

3 LIST OF PRODUCT DOSAGE FORMS * 3.1 Oral Preparation liquid and semi solid 3.2 Oral Preparations solid forms 3.3 Oromucosal and gingival preparations 3.4 Preparations for dental use 3.5 Cutaneous and transdermal preparations 3.6 Eye preparations 3.7 Ear preparations 3.8 Nasal Preparations 3.9 Vaginal Preparations 3.10 Rectal Preparations 3.11 Preparations for inhalation 3.12 Parenteral preparations 3.13 Implants 3.14 Preparations for dialysis 3.15 Preparations for intravesical and urethral use 3.16 Tracheopulmonary preparations 3.17 Endocervical preparations 3.18 Intramammary preparations 3.19 Intrauterin preparations 3.20 Environmental preparations 3.21 Miscellaneous * Optional 3

ANNEX 2 (Optional) Address(es) of contract manufacturing sites 4

ANNEX 3 (Optional) Address(es) of Contract Laboratories 5

ANNEX 4 (Optional) Name of qualified person 6

ANNEX 5 (Optional) Name of person responsible for quality control Name of person responsible for production 7

ANNEX 6 (Optional) Date of Inspection on which Manufacturing Authorisation was granted / / 19 Scope of last Inspection 8

ANNEX 7 (Optional) Products authorised to be manufactured (in accordance with Article 17 of Council Directive 75/319/EEC............ 9